Nichols (LON:NICL – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Berenberg Bank in a report released on Wednesday, Digital Look reports. They presently have a GBX 1,750 price target on the stock. Berenberg Bank’s price target would suggest a potential upside of 61.29% from the company’s current price.
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,150 price objective on shares of Nichols in a report on Thursday, July 30th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Nichols presently has an average rating of “Moderate Buy” and an average price target of GBX 1,400.
View Our Latest Research Report on Nichols
Nichols Stock Down 0.5%
Nichols (LON:NICL – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported GBX 30.30 earnings per share (EPS) for the quarter. Nichols had a return on equity of 24.74% and a net margin of 13.39%. As a group, research analysts forecast that Nichols will post 62.44 EPS for the current fiscal year.
Insider Activity at Nichols
In other news, insider Elizabeth McMeikan purchased 470 shares of Nichols stock in a transaction that occurred on Wednesday, August 12th. The stock was bought at an average price of GBX 1,059 per share, with a total value of £4,977.30. 10.00% of the stock is currently owned by insiders.
About Nichols
Established in 1908, Nichols operates within the resilient soft drinks category and owns or licenses several brands. Nichols is geographically and operationally diversified, operating across three routes to market of UK Packaged, International Packaged and Out of Home.
In the UK, Nichols operates across five soft drinks sub-categories: squash, flavoured carbonates, fruit drinks, energy and flavoured water. Nichols’ portfolio includes the iconic Vimto brand, vitamin-fortified health and wellness brand VITHIT, plus a growing portfolio of licensed brands including MyProtein, Levi Roots, ICEE, and Sunkist.
Featured Stories
- Five stocks we like better than Nichols
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Nichols Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nichols and related companies with MarketBeat.com's FREE daily email newsletter.
